ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

25,675Medicare Part D Prescriptions Filled, Including Refills

Rank: 63 out of 3593

$1.44M Total Retail Price of All Prescriptions

Rank: 58 out of 3593

682 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
67% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 682 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

25% of this provider’s 682 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

4% of this provider’s 20,355 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

38 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
AMLODIPINE BESYLATE 1,364 1,100 1 3
HYDROCODONE-ACETAMINOPHEN 860 595 S3 2 7
PRAVASTATIN SODIUM 848 672 3 13
OMEPRAZOLE 752 612 4 5
LISINOPRIL 698 559 5 2
SIMVASTATIN 678 518 6 1
FUROSEMIDE 647 516 7 9
LOSARTAN POTASSIUM 516 411 8 14
METFORMIN HCL 505 389 9 6
METOPROLOL TARTRATE 479 399 10 8
GLYBURIDE 466 359 R 11 55
POTASSIUM CHLORIDE 417 352 12 24
CARVEDILOL 409 313 13 23
CLOPIDOGREL 397 331 14 30
ALLOPURINOL 392 312 15 35
MUPIROCIN 378 336 16 132
LEVOTHYROXINE SODIUM 376 309 17 4
ALBUTEROL SULFATE 334 285 18 157
RANITIDINE HCL 306 223 19 27
DOXAZOSIN MESYLATE 293 248 20 63
PLAVIX 286 219 21 42
MELOXICAM 284 227 22 29
LOSARTAN-HYDROCHLOROTHIAZIDE 281 197 23 48
MIRTAZAPINE 266 178 24 64
GABAPENTIN 254 162 25 16
KETOCONAZOLE 234 188 26 118
LANTUS 229 142 27 57
LACTULOSE 201 151 28 126
NOVOLIN R 198 155 29 140
GLYBURIDE-METFORMIN HCL 195 126 R 30 95
TAMSULOSIN HCL 181 166 31 33
TRIAMCINOLONE ACETONIDE 176 119 32 119
CEPHALEXIN 176 148 32 150
ATORVASTATIN CALCIUM 172 140 34 15
ZOLPIDEM TARTRATE 168 130 35 12
CIPROFLOXACIN HCL 165 126 36 52
WARFARIN SODIUM 160 142 37 18
AZITHROMYCIN 157 130 38 34
PROAIR HFA 157 152 38 54
LISINOPRIL-HYDROCHLOROTHIAZIDE 145 118 40 26
SERTRALINE HCL 143 116 41 28
PREDNISONE 140 114 42 49
QUETIAPINE FUMARATE 136 107 43 89
DIOVAN 135 132 44 46
LEVETIRACETAM 133 83 45 127
METOPROLOL SUCCINATE 130 114 46 19
KLOR-CON 10 129 99 47 114
ENALAPRIL MALEATE 129 108 47 38
FAMOTIDINE 128 109 49 70
CLONIDINE HCL 127 104 50 41
NAPROXEN 123 94 51 68
GLIMEPIRIDE 121 105 52 44
ATENOLOL 120 112 53 11
TRIAMTERENE-HYDROCHLOROTHIAZID 119 79 54 231
DIGOXIN 119 87 54 58
TRAVATAN Z 118 100 56 292
ADVAIR DISKUS 118 114 56 47
LEVOFLOXACIN 116 107 58 116
NAMENDA 106 106 59 50
DONEPEZIL HCL 106 106 59 31
NOVOLOG 103 65 61 134
NEXIUM 102 79 62 36
NOVOLIN 70-30 102 92 62 146
METHYLPREDNISOLONE 100 88 64 103
FINASTERIDE 99 99 65 79
AMLODIPINE BESYLATE-BENAZEPRIL 96 96 66 65
INSULIN SYRINGE 96 63 66 91
HYDROCHLOROTHIAZIDE 95 62 68 10
SPIRIVA 89 74 69 87
CRESTOR 88 77 70 21
CLOTRIMAZOLE-BETAMETHASONE 86 69 71 94
SULFAMETHOXAZOLE-TRIMETHOPRIM 86 77 71 102
IPRATROPIUM BROMIDE 83 81 73 210
TRIAMTERENE-HCTZ 83 75 73 66
PANTOPRAZOLE SODIUM 81 63 75 45
OCTREOTIDE ACETATE 81 81 10 75 537
TRAMADOL HCL 81 45 75 17
SINGULAIR 80 64 78 77
ISOSORBIDE MONONITRATE ER 77 58 79 61
GLIPIZIDE 73 70 80 40
LEVEMIR 73 72 80 193
VERAPAMIL ER 71 70 82 99
MEGESTROL ACETATE 67 58 R 83 152
FLUTICASONE PROPIONATE 67 61 83 32
NORVIR 65 18 85 183
SEROQUEL XR 64 50 86 199
SANTYL 64 64 86 208
CARISOPRODOL 64 37 R 86 97
FLUOXETINE HCL 64 38 86 60
HUMULIN 70-30 63 57 90 215
DIOVAN HCT 62 58 91 76
LYRICA 61 31 92 105
NITROGLYCERIN PATCH 61 61 92 212
TIMOLOL MALEATE 60 47 94 295
LATANOPROST 60 46 94 195
CARBIDOPA-LEVODOPA 59 51 96 135
PREZISTA 59 12 96 226
HYDRALAZINE HCL 59 44 96 107
CYCLOBENZAPRINE HCL 58 30 R 99 72
AMOX TR-POTASSIUM CLAVULANATE 57 37 100 138
ALPRAZOLAM 57 56 100 37
NIFEDIPINE ER 55 45 102 75
LANTUS SOLOSTAR 55 42 102 122
PAROXETINE HCL 55 53 102 62
COLCRYS 55 46 102 336
HUMULIN N 55 33 102 368
ESCITALOPRAM OXALATE 54 35 107 71
OXYBUTYNIN CHLORIDE 54 50 107 104
PEN NEEDLE 53 40 109 188
MONTELUKAST SODIUM 52 33 110 151
RISPERIDONE 51 51 111 83
ISENTRESS 51 26 111 232
AMITRIPTYLINE HCL 51 41 R 111 90
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 21, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.